BAX Add to watchlist
$17.60 +0.01 (+0.06%)
After Hours: $17.60 +0.00 (+0.00%)
Last updated: Apr 15, 2026 22:49
52-Week Range
$17.60
$15.73 $17.60 $32.68

Fundamentals Overview

Baxter International Inc. is near the low of its 52-week range with low valuation, trading relatively flat today.

Valuation low

P/B 1.48 P/S 0.81

Risk (Beta)

0.62 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 59% confidence Risk: Lower Volatility — Beta 0.62. Diversify and only invest what you can afford to lose.

Pressures (Sell):

Sentiment weakening (3 downgrades) · 3M vs S&P 500: -13.3% · 3M vs Healthcare sector: -6.5%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$9.09B
P/E (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
0.11%
52-Week Range
$15.73 - $32.68
Volume vs Avg
N/A
Beta
0.62

About

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological...
Sector: Healthcare
Headquarters: US
Employees: 38,000
IPO Date: Oct 1981
Beta: 0.62 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: C+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 1, Equal Weight: 3, Hold: 2, Neutral: 13, Outperform: 3, Overweight: 4, Underweight: 4.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $-1.02; current price is $17.60. That’s a -105.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) N/A
PEG (TTM) N/A
P/B (TTM) 1.48
P/S (TTM) 0.81
P/FCF (TTM) 28.13
Liquidity & enterprise
Current Ratio (TTM) 2.31
Quick Ratio (TTM) 1.56
Cash Ratio (TTM) 0.66
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) -8.51%
Gross margin (TTM) 30.05%
Operating margin (TTM) -2.74%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for BAX.

Analyst Sentiment at a Glance

C+ Sentiment Weakening
Buy 1Equal Weight 3Hold 2Neutral 13Outperform 3Overweight 4Underweight 4
0 upgrades, 3 downgrades
Price Target Consensus
Current $17.60
Median $19.50
Consensus $19.75
Low consensus $15.00
High consensus $25.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Evercore ISI Group maintain Outperform Outperform 2026-04-06
Citigroup maintain Neutral Neutral 2026-03-11
Goldman Sachs maintain Neutral Neutral 2026-02-17
Barclays maintain Overweight Overweight 2026-02-13
Barclays maintain Overweight Overweight 2026-01-09
Morgan Stanley maintain Underweight Underweight 2025-12-02
Argus Research downgrade Buy Hold 2025-10-31
Citigroup maintain Neutral Neutral 2025-10-31
Goldman Sachs maintain Neutral Neutral 2025-10-31
UBS maintain Neutral Neutral 2025-10-31
Evercore ISI Group maintain Outperform Outperform 2025-10-07
Barclays maintain Overweight Overweight 2025-08-04
Stifel downgrade Buy Hold 2025-08-04
UBS maintain Neutral Neutral 2025-08-04
Wells Fargo maintain Equal Weight Equal Weight 2025-08-01
Morgan Stanley maintain Underweight Underweight 2025-07-15
Citigroup maintain Neutral Neutral 2025-07-09
Evercore ISI Group maintain Outperform Outperform 2025-07-08
Morgan Stanley maintain Underweight Underweight 2025-05-05
Wells Fargo maintain Equal Weight Equal Weight 2025-05-02
Barclays maintain Overweight Overweight 2025-03-10
JP Morgan maintain Neutral Neutral 2025-02-21
Citigroup maintain Neutral Neutral 2024-12-11
Stifel maintain Buy Buy 2024-11-11
Citigroup maintain Neutral Neutral 2024-10-01
Goldman Sachs maintain Neutral Neutral 2024-08-08
Wells Fargo maintain Equal Weight Equal Weight 2024-08-07
JP Morgan maintain Neutral Neutral 2024-08-07
Morgan Stanley downgrade Equal Weight Underweight 2024-07-15
Citigroup maintain Neutral Neutral 2024-07-10